Have a personal or library account? Click to login
Reactivity of FDA-approved anti-D reagents with partial D red blood cells Cover

Reactivity of FDA-approved anti-D reagents with partial D red blood cells

By: W.J. Judd,  M. Moulds and  G. Schlanser  
Paid access
|May 2020

References

  1. Flegel WA, Wagner FF. Molecular biology of partial D and weak D: implications for blood bank practice. Clin Lab 2002;45:53-9.
  2. Marsh WL. Scoring of hemagglutination reactions. Transfusion 1972;12:352-3.10.1111/j.1537-2995.1972.tb04459.x5072588
  3. Reid ME, Lomas-Francis C. The blood group antigen factsbook. 2nd ed. San Diego, CA: Academic Press, 2004.10.1016/B978-012586585-2/50007-X
  4. Fridey JL. Standards for blood banks and transfusion services. 22nd ed. Bethesda, MD: American Association of Blood Banks, 2003.
  5. Garratty, G. Do we need to be more concerned about weak D antigens? Transfusion 2005;45: 1547-51.10.1111/j.1537-2995.2005.00625.x16181202
DOI: https://doi.org/10.21307/immunohematology-2019-409 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 146 - 148
Published on: May 1, 2020
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 W.J. Judd, M. Moulds, G. Schlanser, published by American National Red Cross
This work is licensed under the Creative Commons License.